Results 1 to 1 of 1
12-14-2012, 11:40 PM #1
Hospira Issues Voluntary Nationwide Recall of Three Lots of Carboplatin Injection Due
Hospira, Inc. (NYSE: HSP), issued this press release today to further inform the general public about a previously communicated voluntary user-level recall of three lots of Carboplatin Injection due to visible particulates identified during a retain sample inspection. Findings have identified the particles as Carboplatin crystals.